Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism
Authors
Keywords
-
Journal
MAYO CLINIC PROCEEDINGS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-20
DOI
10.1016/j.mayocp.2021.04.026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
- (2019) Mette Søgaard et al. Cancer Medicine
- Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
- (2019) Dalene M. Bott-Kitslaar et al. MAYO CLINIC PROCEEDINGS
- Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer‐associated venous thromboembolism
- (2019) Waldemar E. Wysokinski et al. AMERICAN JOURNAL OF HEMATOLOGY
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
- (2019) Nigel S. Key et al. JOURNAL OF CLINICAL ONCOLOGY
- Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
- (2019) Robert D. McBane et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
- (2019) Alejandro Recio-Boiles et al. World Journal of Gastrointestinal Oncology
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
- (2018) A. A. Khorana et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism
- (2012) Martha L. Louzada et al. CIRCULATION
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now